629 related articles for article (PubMed ID: 33421654)
1. Topological Analysis for Sequence Variability: Case Study on more than 2K SARS-CoV-2 sequences of COVID-19 infected 54 countries in comparison with SARS-CoV-1 and MERS-CoV.
Sarkar JP; Saha I; Seal A; Maity D; Maulik U
Infect Genet Evol; 2021 Mar; 88():104708. PubMed ID: 33421654
[TBL] [Abstract][Full Text] [Related]
2. Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses.
Abdelrahman Z; Li M; Wang X
Front Immunol; 2020; 11():552909. PubMed ID: 33013925
[TBL] [Abstract][Full Text] [Related]
3. From SARS and MERS CoVs to SARS-CoV-2: Moving toward more biased codon usage in viral structural and nonstructural genes.
Kandeel M; Ibrahim A; Fayez M; Al-Nazawi M
J Med Virol; 2020 Jun; 92(6):660-666. PubMed ID: 32159237
[TBL] [Abstract][Full Text] [Related]
4. Limited transmissibility of coronavirus (SARS-1, MERS, and SARS-2) in certain regions of Africa.
Ahmed AE
J Med Virol; 2020 Oct; 92(10):1753-1754. PubMed ID: 32270498
[No Abstract] [Full Text] [Related]
5. The unique features of SARS-CoV-2 transmission: Comparison with SARS-CoV, MERS-CoV and 2009 H1N1 pandemic influenza virus.
Wu Z; Harrich D; Li Z; Hu D; Li D
Rev Med Virol; 2021 Mar; 31(2):e2171. PubMed ID: 33350025
[TBL] [Abstract][Full Text] [Related]
6. Genetic variants of the human host influencing the coronavirus-associated phenotypes (SARS, MERS and COVID-19): rapid systematic review and field synopsis.
Di Maria E; Latini A; Borgiani P; Novelli G
Hum Genomics; 2020 Sep; 14(1):30. PubMed ID: 32917282
[TBL] [Abstract][Full Text] [Related]
7. Why COVID-19 Transmission Is More Efficient and Aggressive Than Viral Transmission in Previous Coronavirus Epidemics?
Elrashdy F; Redwan EM; Uversky VN
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32933047
[TBL] [Abstract][Full Text] [Related]
8. Molecular Basis of Pathogenesis of Coronaviruses: A Comparative Genomics Approach to Planetary Health to Prevent Zoonotic Outbreaks in the 21st Century.
Asrani P; Hasan GM; Sohal SS; Hassan MI
OMICS; 2020 Nov; 24(11):634-644. PubMed ID: 32940573
[TBL] [Abstract][Full Text] [Related]
9. Binding affinities of 438 HLA proteins to complete proteomes of seven pandemic viruses and distributions of strongest and weakest HLA peptide binders in populations worldwide.
Barquera R; Collen E; Di D; Buhler S; Teixeira J; Llamas B; Nunes JM; Sanchez-Mazas A
HLA; 2020 Sep; 96(3):277-298. PubMed ID: 32475052
[TBL] [Abstract][Full Text] [Related]
10. The emergence of a novel coronavirus (SARS-CoV-2) disease and their neuroinvasive propensity may affect in COVID-19 patients.
Yashavantha Rao HC; Jayabaskaran C
J Med Virol; 2020 Jul; 92(7):786-790. PubMed ID: 32320066
[TBL] [Abstract][Full Text] [Related]
11. The lethal internal face of the coronaviruses: Kidney tropism of the SARS, MERS, and COVID19 viruses.
Motavalli R; Abdelbasset WK; Rahman HS; Achmad MH; Sergeevna NK; Zekiy AO; Adili A; Khiavi FM; Marofi F; Yousefi M; Ghoreishizadeh S; Shomali N; Etemadi J; Jarahian M
IUBMB Life; 2021 Aug; 73(8):1005-1015. PubMed ID: 34118117
[TBL] [Abstract][Full Text] [Related]
12. Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past.
Shah VK; Firmal P; Alam A; Ganguly D; Chattopadhyay S
Front Immunol; 2020; 11():1949. PubMed ID: 32849654
[TBL] [Abstract][Full Text] [Related]
13. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.
Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY
Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096
[TBL] [Abstract][Full Text] [Related]
14. Emerging coronaviruses: first SARS, second MERS and third SARS-CoV-2: epidemiological updates of COVID-19.
Halaji M; Farahani A; Ranjbar R; Heiat M; Dehkordi FS
Infez Med; 2020 Jun; 28(suppl 1):6-17. PubMed ID: 32532933
[TBL] [Abstract][Full Text] [Related]
15. Severe Acute Respiratory Syndrome Coronavirus (SARS, SARS CoV).
McFee RB
Dis Mon; 2020 Sep; 66(9):101062. PubMed ID: 32800504
[No Abstract] [Full Text] [Related]
16. Ancestral origin, antigenic resemblance and epidemiological insights of novel coronavirus (SARS-CoV-2): Global burden and Bangladesh perspective.
Uddin MB; Hasan M; Harun-Al-Rashid A; Ahsan MI; Imran MAS; Ahmed SSU
Infect Genet Evol; 2020 Oct; 84():104440. PubMed ID: 32622082
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2, SARS-CoV, and MERS-COV: A comparative overview.
Rabaan AA; Al-Ahmed SH; Haque S; Sah R; Tiwari R; Malik YS; Dhama K; Yatoo MI; Bonilla-Aldana DK; Rodriguez-Morales AJ
Infez Med; 2020 Ahead Of Print Jun 1; 28(2):174-184. PubMed ID: 32275259
[TBL] [Abstract][Full Text] [Related]
18. Interspecies Jumping of Bat Coronaviruses.
Wong ACP; Lau SKP; Woo PCY
Viruses; 2021 Oct; 13(11):. PubMed ID: 34834994
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive comparative genomic and microsatellite analysis of SARS, MERS, BAT-SARS, and COVID-19 coronaviruses.
Rehman HA; Ramzan F; Basharat Z; Shakeel M; Khan MUG; Khan IA
J Med Virol; 2021 Jul; 93(7):4382-4391. PubMed ID: 33782990
[TBL] [Abstract][Full Text] [Related]
20. Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review.
Liya G; Yuguang W; Jian L; Huaiping Y; Xue H; Jianwei H; Jiaju M; Youran L; Chen M; Yiqing J
APMIS; 2020 Jun; 128(6):423-432. PubMed ID: 32363707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
